Arterial Stiffness: A Nexus between Cardiac and Renal Disease

Guanghong Jia1, Annayya R Aroor1, James R Sowers2

  • 1Division of Endocrinology, Diabetes, and Metabolism, Mo., USA ; Diabetes Cardiovascular Center, Mo., USA ; Harry S. Truman Memorial Veterans Hospital, Columbia, Mo., USA.

Insights

Arterial stiffening, linked to cardiorenal metabolic syndrome, damages heart and kidney. Understanding these vascular changes can guide new treatments for cardiovascular and chronic kidney diseases.

Area of Science:

  • Cardiovascular science
  • Nephrology
  • Metabolic syndrome research

Background:

  • Vascular disease is a major cause of death globally.
  • Arterial stiffening, a key vascular alteration, results from conditions like obesity, diabetes, hypertension, kidney disease, and aging.
  • This stiffening leads to damage in vital organs such as the heart and kidneys.

Purpose of the Study:

  • To offer new insights into the relationships between arterial stiffness, vascular resistance, and pulse wave velocity.
  • To explore the connection between these hemodynamic alterations and end-organ damage in the heart and kidneys.
  • To highlight the importance of understanding these mechanisms for developing improved therapeutic strategies.

Main Methods:

  • This review synthesizes current research on arterial hemodynamics and end-organ damage.
  • It focuses on the interplay between arterial stiffness, vascular resistance, and pulse wave velocity.
  • Mechanisms linking these factors to heart and kidney damage are examined.

Main Results:

  • Cardiorenal metabolic syndrome factors significantly contribute to arterial stiffening.
  • Arterial stiffness is directly associated with increased vascular resistance and pulse wave velocity.
  • These hemodynamic changes are critical in mediating end-organ damage in the heart and kidneys.

Conclusions:

  • Understanding the mechanisms of arterial functional and hemodynamic alterations is crucial.
  • This knowledge can lead to the development of more effective therapeutic strategies.
  • The ultimate goal is to reduce the burden of cardiovascular disease and chronic kidney disease.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
682
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
8.9K